[
  {
    "generic_name": "Methylphenidate",
    "brand_names": ["Ritalin", "Concerta", "Metadate"],
    "active_ingredients": "Methylphenidate HCl 10mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-8002",
    "nafdac_schedule": "schedule_4",
    "nafdac_schedule_date": "2012-01-01",
    "us_dea_schedule": "Schedule II",
    "uk_controlled_drug_class": "Class B",
    "who_essential_medicine": false,
    "requires_special_prescription": true,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": true,
    "therapeutic_class": "CNS Stimulant",
    "pharmacological_class": "Dopamine/Norepinephrine Reuptake Inhibitor",
    "mechanism_of_action": "Blocks dopamine and norepinephrine reuptake, increasing synaptic concentrations",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "ADHD symptoms, Growth, BP, HR, Abuse signs, Psychiatric symptoms",
    "monitoring_frequency_days": 30,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 6,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Glaucoma", "Severe hypertension", "Hyperthyroidism", "MAOIs within 14 days", "Motor tics or Tourette's syndrome", "Severe anxiety or agitation"],
    "allergy_cross_reactions": ["Other stimulants"],
    "black_box_warning": true,
    "black_box_warning_text": "High potential for abuse and dependence. Misuse may cause sudden death and serious cardiovascular events. Not indicated for normal fatigue. Careful screening for cardiac disease required before prescribing.",
    "major_drug_interactions": ["MAOIs (hypertensive crisis)", "Antihypertensives (reduced effectiveness)", "Warfarin (increased levels)", "SSRIs (serotonin syndrome risk)", "Alcohol"],
    "food_interactions": "Take with or after meals to reduce GI upset, avoid excessive caffeine",
    "search_keywords": ["methylphenidate", "ritalin", "adhd", "add", "stimulant", "attention deficit"],
    "generic_variations": ["Methylphenidate Hydrochloride", "Extended-Release Methylphenidate"],
    "common_misspellings": ["Methylfenidate", "Ritaline", "Methylphenidat"],
    "safer_alternatives": ["Atomoxetine (non-stimulant)", "Guanfacine", "Behavioral therapy"],
    "cheaper_alternatives": ["Dextroamphetamine"],
    "notes": "CNS stimulant for ADHD and narcolepsy. Commonly abused by students for cognitive enhancement. Crushed and snorted or injected for euphoria. May suppress growth in children - monitor height and weight. 'Drug holidays' (stopping on weekends/holidays) sometimes recommended. Cardiovascular screening mandatory before starting. Diversion for non-medical use is common.",
    "is_active": true
  },
  {
    "generic_name": "Dextromethorphan",
    "brand_names": ["Robitussin DM", "Benylin DM", "Delsym"],
    "active_ingredients": "Dextromethorphan Hydrobromide 15mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-8003",
    "nafdac_schedule": "schedule_4",
    "nafdac_schedule_date": "2017-01-01",
    "us_dea_schedule": "not_scheduled",
    "uk_controlled_drug_class": "not_controlled",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 7,
    "requires_photo_id": false,
    "therapeutic_class": "Cough Suppressant",
    "pharmacological_class": "Antitussive",
    "mechanism_of_action": "Acts on cough center in medulla, NMDA receptor antagonist at high doses",
    "is_controlled": true,
    "is_high_risk": false,
    "requires_monitoring": true,
    "monitoring_type": "Cough control, Abuse indicators (especially in adolescents)",
    "monitoring_frequency_days": 7,
    "addiction_risk": true,
    "abuse_potential": "moderate",
    "minimum_age": 12,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": true,
    "major_contraindications": ["MAOIs within 14 days", "Chronic cough (asthma, emphysema)", "Productive cough"],
    "allergy_cross_reactions": ["None known"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["MAOIs (serotonin syndrome, fatal)", "SSRIs (serotonin syndrome)", "CYP2D6 inhibitors (increased levels)", "Quinidine (increased DXM levels)"],
    "food_interactions": "Avoid grapefruit juice, avoid alcohol",
    "search_keywords": ["dextromethorphan", "dxm", "robitussin", "cough syrup", "robotripping"],
    "generic_variations": ["Dextromethorphan Hydrobromide", "Dextromethorphan Polistirex (extended-release)"],
    "common_misspellings": ["Dextromethorphin", "Dextromethorfan", "DXM"],
    "safer_alternatives": ["Honey (for mild cough)", "Codeine (more effective, more controlled)"],
    "cheaper_alternatives": ["Diphenhydramine", "Guaifenesin (expectorant, not suppressant)"],
    "notes": "OTC cough suppressant widely abused by teenagers and young adults for dissociative/hallucinogenic effects ('robotripping', 'skittling'). At high doses (300-1500mg), acts as NMDA antagonist similar to ketamine and PCP. NAFDAC scheduled in 2017 due to abuse epidemic. Four abuse 'plateaus' based on dose. Can cause serotonin syndrome with SSRIs/MAOIs. Age restrictions for purchase in many areas. Often combined with other drugs in multi-ingredient cough/cold products.",
    "is_active": true
  },
  {
    "generic_name": "Pseudoephedrine",
    "brand_names": ["Sudafed", "Actifed", "Sinutab"],
    "active_ingredients": "Pseudoephedrine HCl 60mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-8004",
    "nafdac_schedule": "schedule_4",
    "nafdac_schedule_date": "2006-01-01",
    "us_dea_schedule": "not_scheduled",
    "uk_controlled_drug_class": "not_controlled",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 7,
    "requires_photo_id": true,
    "therapeutic_class": "Decongestant",
    "pharmacological_class": "Sympathomimetic Amine",
    "mechanism_of_action": "Alpha and beta adrenergic agonist, causes vasoconstriction of nasal mucosa",
    "is_controlled": true,
    "is_high_risk": false,
    "requires_monitoring": false,
    "monitoring_type": "Blood pressure, Heart rate (in hypertensive patients)",
    "monitoring_frequency_days": 7,
    "addiction_risk": false,
    "abuse_potential": "low",
    "minimum_age": 12,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Severe hypertension", "Severe coronary artery disease", "MAOIs within 14 days", "Glaucoma"],
    "allergy_cross_reactions": ["Other sympathomimetics", "Ephedrine"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["MAOIs (hypertensive crisis)", "Antihypertensives (reduced effectiveness)", "Digoxin (arrhythmias)", "Beta-blockers (hypertension)"],
    "food_interactions": "Avoid excessive caffeine, take with food if GI upset occurs",
    "search_keywords": ["pseudoephedrine", "sudafed", "decongestant", "nasal congestion", "cold remedy"],
    "generic_variations": ["Pseudoephedrine Hydrochloride", "Pseudoephedrine Sulfate"],
    "common_misspellings": ["Pseudoephedrin", "Sudafed", "Pseudoephedrine"],
    "safer_alternatives": ["Phenylephrine (less effective but not used for meth)", "Nasal saline", "Steam inhalation"],
    "cheaper_alternatives": ["Phenylephrine", "Oxymetazoline nasal spray"],
    "notes": "Effective nasal decongestant but heavily regulated worldwide as precursor for methamphetamine synthesis. NAFDAC requires photo ID, purchase limits, and record-keeping. Behind-the-counter in most countries. Largely replaced by phenylephrine in many OTC products (though phenylephrine is less effective). Causes CNS stimulation, insomnia if taken late in day. Not recommended for extended use (>7 days).",
    "is_active": true
  }
]
